Benzodiazepines

WATSON 836 7.5 Pill - beige five-sided

Pill with imprint WATSON 836 7.5 is Beige, Five-sided and has been identified as Clorazepate Dipotassium 7.5 mg. It is supplied by Watson Laboratories, Inc.

Clorazepate is used in the treatment of Anxiety; Alcohol Withdrawal; Seizure Prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images

Clorazepate (Clorazepate [ klor-az-e-pate ])-WATSON 836 7.5-7.5 mg-Beige-Five-sided
Clorazepate (Clorazepate [ klor-az-e-pate ])-WATSON 836 7.5-7.5 mg-Beige-Five-sided
Clorazepate (Clorazepate [ klor-az-e-pate ])-WATSON 836 7.5-7.5 mg-Beige-Five-sided

Clorazepate
Generic Name: clorazepate [ klor-az-e-pate ]
Imprint: WATSON 836 7.5
Strength: 7.5 mg
Color: Beige
Size: N/A
Shape: Five-sided
Availability: Prescription only
Drug Class: Benzodiazepines
Pregnancy Category: N - Not classified
CSA Schedule: 4 - Some potential for abuse
Labeler / Supplier: N/A
National Drug Code (NDC): 52544-0836 (Discontinued)
Inactive Ingredients:
Latest News
Related Drugs